Hepatology Program News Today

FOSTER CITY - Mirum Pharmaceuticals, Inc. today announced that the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee has recommended public reimbursement for...

- Positive HTA recommendation for reimbursement signifies an important milestone towards public funding to treat eligible patients with this rare liver disorder - LIVMARLI is the first and only...

New study on colonoscopy finds they may not be that effective at preventing colon cancer, death. But you still need regular colon cancer screening, doctors say.

29.09.2022 - Multiple contracts with VA medical centers already executed for Pure-Vu EVS under the sole source supplier designation, with additional centers under evaluationApproximately 645,000 colonoscopies were performed at ~170 VA medical centers over the ... Seite 1

email article A novel protein-based multitarget fecal immunochemical test (mFIT) for colorectal cancer (CRC) screening was superior to conventional FIT in detecting advanced neoplasia, particularly advanced adenomas, Dutch researchers found. If performed on patients every 2 years, mFIT would reduce CRC incidence and death by 12% and 8%, respectively, assuming a 73% adherence rate, compared with conventional FIT screening, reported Meike de Wit, PhD, of The Netherlands Cancer Institute in ...